Previous close | 17.02 |
Open | 17.13 |
Bid | 16.75 x 200 |
Ask | 16.83 x 100 |
Day's range | 16.75 - 17.27 |
52-week range | 15.32 - 29.70 |
Volume | |
Avg. volume | 377,040 |
Market cap | 650.965M |
Beta (5Y monthly) | 1.33 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Quanterix Corporation ( NASDAQ:QTRX ) shareholders might be concerned after seeing the share price drop 13% in the last...
Quanterix's (QTRX) blood-based biomarker test offers a non-invasive alternative, potentially revolutionizing how AD is diagnosed and managed.
It's been a good week for Quanterix Corporation ( NASDAQ:QTRX ) shareholders, because the company has just released its...